company overview description of the company and business segments becton, dickinson and company ("bd") is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. the company's organizational structure is based upon two principal business segments, bd medical ("medical") and bd life sciences ("life sciences").
we continue to invest in research and development, geographic expansion, and new product promotions to drive further revenue and profit growth. our ability to sustain our long-term growth will depend on a number of factors, including our ability to expand our core business (including geographical expansion), develop innovative new products, and continue to improve operating efficiency and organizational effectiveness. while the economic environment for the healthcare industry has stabilized, pricing pressures continue for some of our products. healthcare utilization has stabilized and slightly improved in the united states; however, any destabilization in the future could adversely impact our u.s. businesses. additionally, macroeconomic challenges in europe continue to constrain healthcare utilization, although we currently view the environment as stable. in emerging markets, the company's growth is dependent primarily on government funding for healthcare systems.
results of operations medical segment the following is a summary of medical revenues by organizational unit:
life sciences segment the following is a summary of life sciences revenues by organizational unit: